Nifty
Sensex
:
:
11532.40
38363.47
70.20 (0.61%)
268.40 (0.70%)

Pharmaceuticals & Drugs

Rating :
73/99

BSE: 512529 | NSE: SEQUENT

79.00
1.85 (2.40%)
19-Mar-2019 | 3:59PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  77.45
  •  80.90
  •  76.75
  •  77.15
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  2086723
  •  1648.51
  •  89.25
  •  42.65

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,880.42
  • 4.36
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 2,142.55
  • 0.26%
  • 2.93

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 57.41%
  • 11.68%
  • 13.20%
  • FII
  • DII
  • Others
  • 0.11%
  • 4.07%
  • 13.53%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 24.30
  • 22.73
  • 26.61

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 41.55
  • 97.45
  • 54.77

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 60.78
  • -
  • 239.46

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 7.00
  • 9.49
  • 2.89

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 55.69
  • 86.17
  • 32.50

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 18
Dec 17
Var%
Sep 18
Sep 17
Var%
Jun 18
Jun 17
Var%
Mar 18
Mar 17
Var%
Net Sales
270.53
224.92
20.28%
251.72
197.54
27.43%
235.15
194.23
21.07%
232.76
200.33
16.19%
Expenses
234.84
206.16
13.91%
223.99
178.65
25.38%
212.64
179.16
18.69%
202.51
177.00
14.41%
EBITDA
35.69
18.76
90.25%
27.73
18.89
46.80%
22.52
15.08
49.34%
30.25
23.33
29.66%
EBIDTM
13.19%
8.34%
11.02%
9.57%
9.58%
7.76%
13.00%
11.64%
Other Income
1.99
3.44
-42.15%
2.44
6.60
-63.03%
1.81
3.62
-50.00%
2.92
0.08
3,550.00%
Interest
8.35
9.87
-15.40%
7.77
7.42
4.72%
7.78
6.10
27.54%
9.68
7.26
33.33%
Depreciation
11.16
11.73
-4.86%
10.20
10.05
1.49%
9.64
10.08
-4.37%
9.48
9.50
-0.21%
PBT
18.17
0.60
2,928.33%
12.20
8.03
51.93%
6.91
2.51
175.30%
12.51
6.66
87.84%
Tax
2.60
3.63
-28.37%
-3.30
3.83
-
2.43
1.93
25.91%
4.08
-4.84
-
PAT
15.57
-3.03
-
15.50
4.20
269.05%
4.48
0.59
659.32%
8.43
11.50
-26.70%
PATM
5.76%
-1.35%
6.16%
2.13%
1.91%
0.30%
3.62%
5.74%
EPS
0.53
-0.39
-
0.62
1.20
-48.33%
0.13
0.09
44.44%
16.39
0.28
5,753.57%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Net Sales
990.16
1,268.48
683.57
624.98
465.36
455.46
326.86
345.81
311.89
284.45
144.02
Net Sales Growth
21.19%
85.57%
9.37%
34.30%
2.17%
39.34%
-5.48%
10.88%
9.65%
97.51%
 
Cost Of Goods Sold
522.31
462.17
356.70
311.71
240.72
243.65
181.72
192.27
162.01
127.65
66.55
Gross Profit
467.85
806.32
326.87
313.27
224.65
211.81
145.14
153.53
149.87
156.80
77.48
GP Margin
47.25%
63.57%
47.82%
50.12%
48.27%
46.50%
44.40%
44.40%
48.05%
55.12%
53.80%
Total Expenditure
873.98
764.86
643.03
568.27
444.87
438.68
342.51
308.74
266.39
229.58
151.64
Power & Fuel Cost
-
14.66
12.77
26.51
23.32
22.06
23.53
20.21
16.75
14.40
18.72
% Of Sales
-
1.16%
1.87%
4.24%
5.01%
4.84%
7.20%
5.84%
5.37%
5.06%
13.00%
Employee Cost
-
113.83
106.22
88.62
62.39
48.12
41.47
29.40
29.82
27.57
20.82
% Of Sales
-
8.97%
15.54%
14.18%
13.41%
10.57%
12.69%
8.50%
9.56%
9.69%
14.46%
Manufacturing Exp.
-
59.07
57.63
72.14
54.31
52.30
41.42
27.88
33.72
29.76
28.40
% Of Sales
-
4.66%
8.43%
11.54%
11.67%
11.48%
12.67%
8.06%
10.81%
10.46%
19.72%
General & Admin Exp.
-
57.35
48.60
36.44
33.79
43.58
23.96
13.69
15.95
17.85
9.06
% Of Sales
-
4.52%
7.11%
5.83%
7.26%
9.57%
7.33%
3.96%
5.11%
6.28%
6.29%
Selling & Distn. Exp.
-
36.87
28.78
17.46
20.27
12.30
10.51
9.23
7.52
7.01
4.31
% Of Sales
-
2.91%
4.21%
2.79%
4.36%
2.70%
3.22%
2.67%
2.41%
2.46%
2.99%
Miscellaneous Exp.
-
20.92
32.34
15.40
10.07
16.66
19.91
16.05
0.63
5.34
4.31
% Of Sales
-
1.65%
4.73%
2.46%
2.16%
3.66%
6.09%
4.64%
0.20%
1.88%
2.63%
EBITDA
116.19
503.62
40.54
56.71
20.49
16.78
-15.65
37.07
45.50
54.87
-7.62
EBITDA Margin
11.73%
39.70%
5.93%
9.07%
4.40%
3.68%
-4.79%
10.72%
14.59%
19.29%
-5.29%
Other Income
9.16
16.58
11.08
14.30
9.96
3.84
4.96
10.48
6.69
30.02
6.51
Interest
33.58
33.07
28.34
38.56
44.37
39.04
33.45
29.99
23.80
21.66
5.05
Depreciation
40.48
41.34
40.07
46.22
32.94
32.60
28.61
22.98
20.69
14.24
6.48
PBT
49.79
445.79
-16.80
-13.77
-46.85
-51.00
-72.75
-5.41
7.69
48.98
-12.64
Tax
5.81
13.46
-0.41
2.62
3.39
0.58
-8.06
-3.95
7.51
8.53
2.02
Tax Rate
11.67%
3.03%
2.44%
-19.03%
-40.50%
-0.53%
11.08%
73.01%
215.80%
21.59%
-15.98%
PAT
43.98
421.57
-13.83
-18.47
-10.74
-110.49
-64.69
-1.40
-0.17
37.42
-14.66
PAT before Minority Interest
34.81
430.83
-16.39
-16.39
-11.76
-110.49
-64.69
-1.46
-4.02
30.97
-14.66
Minority Interest
-9.17
-9.26
2.56
-2.08
1.02
0.00
0.00
0.06
3.85
6.45
0.00
PAT Margin
4.44%
33.23%
-2.02%
-2.96%
-2.31%
-24.26%
-19.79%
-0.40%
-0.05%
13.16%
-10.18%
PAT Growth
231.67%
-
-
-
-
-
-
-
-
-
 
Unadjusted EPS
17.67
17.40
-0.57
-0.92
-0.75
-42.76
-29.56
-0.64
-0.08
17.62
-13.22

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Shareholder's Funds
647.58
976.79
945.71
91.27
56.73
95.00
122.53
123.06
111.78
40.52
Share Capital
48.75
48.75
47.65
30.48
26.74
23.44
21.34
21.23
21.93
11.09
Total Reserves
581.25
912.49
874.01
26.85
-0.37
59.68
101.19
101.82
90.55
29.43
Non-Current Liabilities
227.13
246.20
299.72
277.55
159.23
144.35
104.79
123.22
182.42
99.41
Secured Loans
85.14
141.76
197.50
249.97
150.52
137.32
80.19
90.73
153.27
78.28
Unsecured Loans
18.40
23.38
13.82
0.35
0.56
0.72
0.88
8.46
21.85
18.72
Long Term Provisions
28.54
34.76
28.66
25.70
8.03
6.09
15.49
11.74
0.00
0.00
Current Liabilities
430.93
663.55
290.37
406.09
405.28
345.41
329.56
199.21
84.66
95.12
Trade Payables
160.49
203.04
143.94
90.94
114.59
150.91
123.94
82.61
57.71
62.70
Other Current Liabilities
106.52
259.26
83.23
107.43
56.80
35.63
75.38
37.71
5.30
5.68
Short Term Borrowings
152.41
194.70
56.04
204.31
226.60
151.76
123.34
69.09
0.00
0.00
Short Term Provisions
11.51
6.54
7.17
3.42
7.29
7.12
6.89
9.80
21.66
26.74
Total Liabilities
1,342.62
1,903.76
1,538.02
921.84
625.82
589.34
562.37
446.25
381.97
255.52
Net Block
475.97
684.33
586.48
474.43
237.59
227.26
229.76
210.76
184.95
106.84
Gross Block
581.74
789.60
643.70
596.25
369.07
330.69
305.11
264.26
226.06
125.43
Accumulated Depreciation
105.77
105.27
57.22
121.82
131.48
103.43
75.35
53.50
41.11
18.58
Non Current Assets
804.61
1,176.02
1,047.48
612.00
359.87
358.31
351.94
282.23
208.61
138.34
Capital Work in Progress
18.04
32.55
23.52
39.06
43.04
88.71
64.07
19.53
23.63
16.45
Non Current Investment
221.73
363.97
360.58
58.04
0.04
1.64
0.04
0.05
0.03
15.04
Long Term Loans & Adv.
32.42
37.51
30.35
36.01
76.06
39.28
55.77
50.87
0.00
0.00
Other Non Current Assets
56.44
57.66
46.54
4.47
3.15
1.42
2.30
1.02
0.00
0.00
Current Assets
538.01
727.74
490.54
309.84
265.94
231.04
210.42
164.02
173.36
117.17
Current Investments
17.34
64.12
66.98
0.58
0.08
0.18
0.28
0.33
0.51
0.35
Inventories
158.57
160.81
135.08
94.36
101.40
85.62
68.24
65.55
56.31
31.98
Sundry Debtors
258.35
254.62
192.39
115.44
83.54
65.81
70.41
55.45
55.38
39.45
Cash & Bank
42.45
47.40
25.30
38.46
36.21
33.00
35.88
9.17
14.07
4.10
Other Current Assets
61.30
146.31
24.11
19.15
44.71
46.44
35.62
33.52
47.08
41.28
Short Term Loans & Adv.
56.05
54.48
46.69
41.86
37.47
36.48
28.84
31.25
38.25
27.42
Net Current Assets
107.08
64.19
200.17
-96.25
-139.34
-114.37
-119.13
-35.19
88.70
22.05
Total Assets
1,342.62
1,903.76
1,538.02
921.84
625.81
589.35
562.36
446.25
381.97
255.51

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Cash From Operating Activity
45.24
-7.19
-0.05
-23.55
-44.78
-3.82
21.48
49.63
16.89
-4.98
PBT
445.79
-16.80
-13.77
-8.37
-109.91
-72.75
-5.41
3.49
39.49
-12.64
Adjustment
-313.85
123.31
83.81
35.92
133.52
65.98
46.98
36.77
27.17
10.31
Changes in Working Capital
-77.87
-104.37
-71.46
-53.98
-67.45
2.48
-17.29
15.96
-46.23
-0.79
Cash after chg. in Working capital
54.06
2.14
-1.42
-26.44
-43.84
-4.28
24.27
56.22
20.44
-3.12
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-8.83
-9.33
1.37
2.89
-0.95
0.46
-2.79
-6.59
-3.54
-1.86
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
7.17
-116.18
-315.83
-154.69
-79.95
-54.89
-66.78
-71.77
-4.06
-29.37
Net Fixed Assets
221.87
-49.63
97.97
38.51
-26.62
-28.82
-41.67
-80.90
-111.64
-13.87
Net Investments
210.25
0.26
-713.97
-118.07
-10.37
-15.66
-25.20
31.50
-21.31
-14.05
Others
-424.95
-66.81
300.17
-75.13
-42.96
-10.41
0.09
-22.37
128.89
-1.45
Cash from Financing Activity
-56.96
147.44
308.69
179.41
145.54
34.70
61.94
16.51
-5.95
34.32
Net Cash Inflow / Outflow
-4.55
24.07
-7.19
1.17
20.80
-24.02
16.63
-5.62
6.89
-0.03
Opening Cash & Equivalents
44.10
20.03
21.85
22.96
3.45
27.37
9.17
14.07
4.10
4.13
Closing Cash & Equivalent
39.54
44.10
20.03
21.83
22.96
3.45
27.37
9.17
14.07
4.10

Financial Ratios

Consolidated /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Book Value (Rs.)
25.85
39.44
38.69
3.76
1.97
7.09
11.48
11.59
10.26
7.31
ROA
26.54%
-0.95%
-1.33%
-1.52%
-18.19%
-11.23%
-0.29%
-0.97%
9.72%
-8.24%
ROE
54.15%
-1.74%
-3.35%
-28.10%
-201.83%
-62.91%
-1.19%
-3.42%
40.48%
-29.95%
ROCE
40.72%
0.87%
2.72%
6.93%
-16.09%
-9.86%
6.98%
9.11%
28.82%
-6.90%
Fixed Asset Turnover
1.85
0.96
1.03
1.01
1.36
1.08
1.26
1.31
1.66
1.69
Receivable days
73.71
118.40
87.75
74.80
57.30
72.70
64.08
63.08
59.42
74.65
Inventory Days
45.89
78.37
65.41
73.58
71.75
82.12
68.11
69.36
55.33
58.62
Payable days
89.49
104.11
77.28
87.31
115.68
149.32
123.09
94.20
96.41
93.36
Cash Conversion Cycle
30.11
92.66
75.87
61.07
13.36
5.51
9.10
38.25
18.34
39.91
Total Debt/Equity
0.48
0.43
0.34
8.26
15.86
3.74
2.19
1.54
1.56
2.39
Interest Cover
14.44
0.41
0.64
0.81
-1.82
-1.18
0.82
1.15
2.82
-1.50

News Update:


  • Sequent Scientific - Quarterly Results
    1st Feb 2019, 12:55 PM

    Read More
  • Sequent Scientific’s arm receives EIR for Analytical Lab at Mangalore
    13th Dec 2018, 14:06 PM

    SRL has received EIR from the USFDA

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.